Tech Company Financing Transactions
Axikin Pharmaceuticals Funding Round
Private investors participated in a $6 million capital raise for Axikin Pharmaceuticals. This venture round was announced on 3/27/2014.
Transaction Overview
Company Name
Announced On
3/27/2014
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This filing includes amounts receivable by the Company upon the exercise of Warrants to purchase shares of the Company's Common Stock, assuming no cashless exercise. Such Warrants have not yet been issued. Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10835 Road To The Cure 250
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Axikin Pharmaceuticals develops small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Kevin Bacon
Browse more venture capital transactions:
Prev: 3/27/2014: Sprig venture capital transaction
Next: 3/27/2014: Variation Biotechnologies venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs